Alpharadin (BAY88-8223)

BAY88-8223 · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alpharadin (BAY88-8223), covering 2014-06-25 to 2014-06-25. Get the full timeline:

Most recent: Clinical Trial Update: BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease [Phase 2]